国产人妖在线视频I午夜av一区二区三区I国产色一区二区I一级片视频在线观看I一级毛片儿I亚色图I丁香花一区二区I超碰97在线免费I久久精品中文字幕I日韩在线视频观看免费I无码中文字幕色专区I欧美专区亚洲专区I国产tv在线观看I2024最新黄色网址I日本老妇高潮乱hdI成人免费入口I日韩精品视频在线看I国产传媒在线播放I一本岛视频在线观看I自拍日韩亚洲一区在线I国产成人亚洲综合a∨婷婷I国产精品2019I色亚洲天堂Iav黄色免费I欧美大尺度视频

The activation of CD8+ T cells by antigen cross-presentation is very effective in eliminating tumors. Although this function is traditionally attributed to dendritic cells, tumor-associated macrophages (TAM) can also cross-present antigens. At the same time, TAM is also the most abundant tumor infiltrating white blood cells. TAM is mainly an anti-inflammatory M2 phenotype. It overexpresses growth factors that promote angiogenesis (e.g., vascular endothelial growth factor A), proteases that promote metastasis (e.g., matrix metalloproteinases), and inhibitory molecules (e.g., ARG1, IL). -10 and PDL1) to suppress the adaptive immune response. Consumption of TAM can inhibit tumor growth and metastasis, and high TAM abundance is closely related to the survival rate of patients with many cancer types. This indicates that M2-like TAM may become a promising research target in the development of anti-tumor therapy. However, because the mechanism by which TAM regulates its ability to cross-present antigens is not fully understood, TAM has not been used to activate CD8+ T cells.